<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to investigate whether <z:chebi fb="3" ids="44915">propofol</z:chebi> could provide postconditioning to ischemic brain injury and the role of <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi>-3-kinase/Akt (PI3K/Akt) pathway in this phenomenon </plain></SENT>
<SENT sid="1" pm="."><plain>Rats underwent 2 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) followed by 22 h of reperfusion were randomly divided into nine groups (n=15 each): sham-operated group, MCAO group, <z:chebi fb="3" ids="44915">propofol</z:chebi> 10, 20 and 35 mg x kg(-1) x h(-1) group (<z:chebi fb="3" ids="44915">propofol</z:chebi> 10, 20, 35 mg x kg(-1) x h(-1) infused at the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion for 30 min), <z:chebi fb="0" ids="52289">wortmannin</z:chebi> group (<z:chebi fb="0" ids="52289">wortmannin</z:chebi> 0.6 mg/kg administered 30 min before MCAO), and the other three groups received <z:chebi fb="0" ids="52289">wortmannin</z:chebi> followed by 10, 20 and 35 mg x kg(-1) x h(-1) <z:chebi fb="3" ids="44915">propofol</z:chebi> respectively </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> at doses of 10 and 20 mg x kg(-1) x h(-1) significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, decreased neurological deficit scores and attenuated neuron <z:mpath ids='MPATH_3'>apoptosis</z:mpath> compared with MCAO group alone </plain></SENT>
<SENT sid="3" pm="."><plain>Increased phosphorylated Akt (P-Akt) was observed in the ischemic penumbra of <z:chebi fb="3" ids="44915">propofol</z:chebi> 10 and 20 mg x kg(-1) x h(-1) group after transient MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>The selective PI3K inhibitor, <z:chebi fb="0" ids="52289">wortmannin</z:chebi> partly eliminated the neuroprotective effect and the elevation of P-Akt expression in ischemic penumbra induced by <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> at dose of 35 mg x kg(-1) x h(-1) did not affect <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neurological deficit scores, neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and the level of P-Akt in transient MCAO rats </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, these results demonstrated that <z:chebi fb="3" ids="44915">propofol</z:chebi> at doses of 10 or 20 mg x kg(-1) x h(-1) infused at the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion for 30 min could provide neuroprotection to transient MCAO rats, and the postconditioning effect induced by <z:chebi fb="3" ids="44915">propofol</z:chebi> partly through maintaining the activity of PI3K/Akt pathway </plain></SENT>
</text></document>